Comparison
2p21 Microdeletion Syndrome C4304537 vs 16p11 2p12 2 Microduplication Syndrome C4518821
Clinical comparison between 2p21 Microdeletion Syndrome and 16p11 2p12 2 Microduplication Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome C4304537
A rare genetic disorder involving deletion of genetic material on chromosome 2. It may affect multiple body systems and development. Management is tailored to individual symptoms.
16p11 2p12 2 Microduplication Syndrome C4518821
A rare genetic condition involving extra genetic material on chromosome 16. It may affect development and be associated with developmental delays, learning difficulties, and distinctive features in some individuals. Management involves supportive therapies.
6 comparison axes
Onset
2p21 Microdeletion Syndrome C4304537
0-null
16p11 2p12 2 Microduplication Syndrome C4518821
0-null
Onset patterns differ
Severity
2p21 Microdeletion Syndrome C4304537
severe
16p11 2p12 2 Microduplication Syndrome C4518821
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome C4304537
Chronic
16p11 2p12 2 Microduplication Syndrome C4518821
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome C4304537
No
16p11 2p12 2 Microduplication Syndrome C4518821
No
Different transmission
Body System
2p21 Microdeletion Syndrome C4304537
congenital
16p11 2p12 2 Microduplication Syndrome C4518821
congenital
Same/different system
Category
2p21 Microdeletion Syndrome C4304537
rare-disease
16p11 2p12 2 Microduplication Syndrome C4518821
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-C4304537 and 16p11-2p12-2-microduplication-syndrome-C4518821 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome C4304537 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Discriminating power |
|---|---|---|---|
| Genomic change | Missing material at 2p21. | Extra material spanning 16p11.2 to 16p12.2. | High |
| Developmental impact | May affect multiple systems and development; exact pattern is not established here. | May include developmental delay, learning difficulty, and distinctive features in some people. | Moderate |
| Reported severity | Source severity is severe, with substantial individual variation possible. | Source severity is moderate, but severity is not uniform. | Low |
When to favor each condition
Choose 2p21 Microdeletion Syndrome C4304537 when
A confirmed deletion involves 2p21.
The chromosomal locus and deletion type match the left condition.
High
Multiple congenital or developmental concerns accompany a 2p21 deletion.
This is consistent with the supplied multisystem description, without proving a specific phenotype.
Moderate
Severity appears marked.
The source labels it severe, but clinical severity alone cannot establish the diagnosis.
Low
Choose 16p11 2p12 2 Microduplication Syndrome C4518821 when
A confirmed duplication spans 16p11.2p12.2.
The locus and duplication type distinguish it from a 2p21 deletion.
High
Developmental delay or learning difficulty is the main concern.
These are mentioned for the right condition, but they are not specific.
Moderate
Features are relatively limited.
The source labels severity moderate, yet phenotype overlap remains possible.
Low
How key tests differ
| Test | 2p21 Microdeletion Syndrome C4304537 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a 2p21 deletion. | May detect a 16p11.2p12.2 duplication. | The copy-number result, not symptoms alone, distinguishes the conditions. |
| Confirmatory cytogenetic testing | May support a deletion when appropriately targeted. | May support a duplication when appropriately targeted. | Method and resolution must be chosen by a genetics laboratory. |
| Clinical assessment | Looks for multisystem and developmental effects. | Looks for developmental, learning, and physical findings. | Assessment guides care but does not replace genomic confirmation. |
Prognosis comparison
2p21 Microdeletion Syndrome C4304537
- Outcome
- Long-term outcome is not established in the supplied data.
- Factors
- Reported severe label, affected systems, and developmental needs.
16p11 2p12 2 Microduplication Syndrome C4518821
- Outcome
- Long-term outcome is not established in the supplied data.
- Factors
- Reported moderate label, learning needs, and available supports.
Time frame: No reliable time frame is supplied.
Individual findings, confirmed genomic result, and access to supportive care.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Possible broad developmental effects. Possible delay and learning difficulty. Specific complications are not established by the supplied descriptions. |
| Multisystem involvement | Multiple body systems may be affected. Distinctive features may occur in some individuals. Organ-specific risks should not be inferred without evaluation. |
| Support needs | Management is individualized to symptoms. Supportive therapies are central. Neither description establishes a uniform complication profile. |
Patient education highlights
- HighDiagnosis
A chromosomal test result is not the same as predicting every future symptom.
- HighCare
Management is supportive and tailored; no treatment dose is established here.
- MediumInheritance counseling
A genetics professional should discuss recurrence and family testing.